Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital Trends
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

Contact Us

Search

CAR T

Endocrinology

Endocrinology Weekly Update - May 6th 2025

🔬 Latest Endocrinology Breakthroughs: Diabetes, Thyroid Cancer, AI Tools &…

Hematology

Hematology Weekly News - April 14th 2025

🩸 Hematology Headlines You Shouldn’t Miss This Week Welcome to this week’s…

Hematology

Hematology Weekly News - March 31st 2025

🔬🩸 Hematology Updates: CAR-T Advancements, RNA Therapies, and Key Clinical…

Hematology

Hematology Weekly News - March 24th 2025

🔬 Latest Hematology Updates: Cutting-edge 🧬 gene therapies, game-changing 💉 CAR…

Hematology

Hematology Weekly News - March 17th 2025

🚀 Hematology News: Advancements in blood cancers, acute and chronic leukemias,…

Hematology

Hematology Weekly News - March 11th 2025

🔬 Hematology Breakthroughs: Clinical trial results, new FDA approvals, and…

Hematology

Hematology Weekly News - February 17th 2025

🔬 Hematology & Blood Cancer Updates: Weekly Clinical Research & FDA…

Hematology

Hematology Weekly News - February 10th 2025

Hematology Updates: Mim8, Breyanzi, Axi-Cel, Ziftomenib, CAR-T, DLBCL, MCL,…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Endocrinology Video Recap—January 27, 2026
Endocrinology Today—January 27, 2026
Obesity Today—January 27, 2026
Lucid Diligence Brief: Fortitude Biomedicines launch with $13M seed
Hematology Video Recap—January 26, 2026

Tags

AB Science advanced therapies avian influenza B-cell architecture analysis bioinformatics cancer Cardiovascular strategy Chugai ckd Clover Biopharmaceuticals Congenital disorder of glycosylation corporate venture capital drug pricing drug supply chain Elranatamab enterprise AI ESMO 2021 FDA respiratory approvals French National Agency for the Safety of Medicines and Health Products gene editing gene therapy approval Glaucoma Global obesity market Global women’s health market HBICE hematology Infectious disease preparedness influenza transmission investment Medical Care Technologies MindRank nanotechnology NFTs in healthcare non viral vectors oncology trials pharma Pimicotinib Plasma value chain remote patient monitoring Sema4 Spinal and bulbar muscular atrophy Tahoe Therapeutics tissue engineering Tvardi Therapeutics unconventional trial designs

Archives

Archives

1
2
3

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Endocrinology Video Recap—January 27, 2026
Endocrinology Today—January 27, 2026
Obesity Today—January 27, 2026
Lucid Diligence Brief: Fortitude Biomedicines launch with $13M seed
Hematology Video Recap—January 26, 2026

TAGS

AB Science advanced therapies avian influenza B-cell architecture analysis bioinformatics cancer Cardiovascular strategy Chugai ckd Clover Biopharmaceuticals Congenital disorder of glycosylation corporate venture capital drug pricing drug supply chain Elranatamab enterprise AI ESMO 2021 FDA respiratory approvals French National Agency for the Safety of Medicines and Health Products gene editing gene therapy approval Glaucoma Global obesity market Global women’s health market HBICE hematology Infectious disease preparedness influenza transmission investment Medical Care Technologies MindRank nanotechnology NFTs in healthcare non viral vectors oncology trials pharma Pimicotinib Plasma value chain remote patient monitoring Sema4 Spinal and bulbar muscular atrophy Tahoe Therapeutics tissue engineering Tvardi Therapeutics unconventional trial designs

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital Trends
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
LucidWargames
QuickAnswers
LucidSearch
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy